Study of Postoperative Ileus in Digestive Surgery
ConditionColorectal Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
Post-operative ileus is a temporary stoppage of bowel function following surgery. Indeed it can occur in 20% of cases during post-operative follow-up of bowel surgery. The absence of resumption of transit can lead to the implementation of specific treatments such as the placement of a nasogastric tube and drug treatments. To date, the definition of this event is not accepted by everyone and is not based on reproducible evaluation criteria. The main objective of this study is to evaluate a score used to date to define postoperative ileus, the IFEED score, and to compare it to the length of postoperative stay.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Colorectal cancer
Chronic inflammatory bowel disease
Colonic diverticulosis.
Disqualifiers
Patient treated for digestive resection with associated resection procedure or to be treated with intraperitoneal chemotherapy.
Patient presenting during hospitalization with an ileus secondary to another intra-abdominal complication.
Patient cared for in an emergency
Hepatic resection or other associated metastatic site
Trial population
Population who have planned abdominal surgery
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Post-operative ileus surgery
Other interventionCollection of ileus events, items of IFEED score and surgical complications
Treatment groups
161 Participants
are divided into 1 treatment groupGroup A: Adult patients with digestive surgery1 intervention
Trial outcomes
Primary outcomes
1
Complications of post-operative ileus surgery
Correlation between length of stay and Intake-Feeling nauseated-Emesis-physical Exam-Duration of symptoms (IFEED) score.
Time frame
1 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Toulouse
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov